title: How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
authors.forename: George P
authors.initials: GP
authors.lastname: Canellos
authors.forename: David
authors.initials: D
authors.lastname: Duggan
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Johnson
authors.forename: Donna
authors.initials: D
authors.lastname: Niedzwiecki
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use*; D003606:Dacarbazine / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D014747:Vinblastine / Q000627:therapeutic use*
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin